A one‑year course of T‑DM1 offers excellent cancer‑free survival for early HER2‑positive breast cancer, with far less nerve ...

His method of producing the drug Taxol, now used widely to treat various cancers, eliminated the need to source its active compound from endangered trees. By Delthia Ricks Robert A. Holton, a chemist ...

A chemotherapy drug could cause "significant" hearing loss among cancer survivors, according to a study from the University of South Florida and Indiana University. Researchers tracked 100 testicular ...

The Florida State University community mourns the loss of esteemed chemist and noted inventor Robert Holton, whose groundbreaking synthesis of the cancer drug Taxol made it widely available to ...

Cancer care today is collaborative. Doctors present options, explain benefits and risks and work with patients to choose a plan that aligns with their goals and values. Seeking a second opinion is ...

The demand for the widely used cancer drug Taxol is increasing, but it's difficult and expensive to produce because it hasn't been possible to do it biosynthetically. Until now, that is. Researchers ...

After decades, scientists have finally pieced together the 23-step biosynthetic pathway to produce this cancer drug ...

For many women with breast cancer, the very treatment that saves their lives can also bring fatigue, loss of muscle mass, emotional strain and other daunting obstacles. A new study shows that exercise ...

The demand for the widely used cancer drug Taxol is increasing, but it's difficult and expensive to produce because it hasn't been possible to do it biosynthetically. Until now, that is. Researchers ...

The widely used chemotherapy drug Taxol does not work for the most common form of breast cancer and helps far fewer patients than has been believed, surprising new research suggests. If further study ...

The blood pressure drug Losartan may be able to block a gene found in the blood, angiotensin II receptor type 1 (AGTR1), and improve the effectiveness of chemotherapy, according to a study published ...

Optune Pax® with the chemotherapy combination of gemcitabine and nab-paclitaxel is the first treatment to be FDA approved in nearly 30 years for locally advanced pancreatic cancer.